To evaluate the tau phosphorylation level in the EC region of PART and AD patients, immunohistochemistry (IHC) for the p‐tau S202/T205 (AT8) were performed (n = 43 for AD; n = 40 for PART; Figure 1A). Here, MAPT is linked to Alzheimer disease.